New application data for PVA portfolio increases efficiencyIssue: December 17, 2014
| Category: Bioavailability, Formulation
In order to provide the best support for your formulation processes, and help you save time and make your work more efficient, we have collected new application data for our PVA portfolio, including dissolution rate, molecular weight and thermal stability. PVA is a synthetic, biocompatible, and toxicologically safe polymer that can be used as a matrix former for sustained release hydrogel drug delivery systems and is well suited for a variety of pharmaceutical applications, including solid, liquid, and semi-solid formulations. To address your PVA needs for your excipient application, Merck offers the broadest portfolio of pharmaceutical-grade PVAs, backed by our EMPROVE® documentation and is available in a variety of viscosities and grades of hydrolysis. For more information about PVA, please contact your local sales representative or click the button below. For more information, please click here In This Same Issue: |
Recent Articles
Article Search
Article Archives
Events
Webinars
|